Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 1/20 | 0.43 |
| ▸ | TPSAB1 | Q15661 | 7/20 | 0.41 |
| ▸ | KRAS | P01116 | 3/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.39 |
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | MC4R | P32245 | 3/20 | 0.37 |
| ▸ | MC5R | P33032 | 3/20 | 0.37 |
| ▸ | MC3R | P41968 | 3/20 | 0.37 |
| ▸ | MC1R | Q01726 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29925329 | 1.00 | FURIN (0.43) | FURINTPSAB1KRASCXCR4SIRT2 | |
| SCHEMBL29925268 | 1.00 | FURIN (0.43) | FURINTPSAB1KRASCXCR4SIRT2 | |
| SCHEMBL31328348 | 0.93 | TPSAB1 (0.43) | FURINTPSAB1KRASCXCR4MC4R | |
| SCHEMBL12794626 | 0.89 | KRAS (0.48) | FURINTPSAB1KRASCXCR4 | |
| SCHEMBL29569694 | 0.87 | GHSR (0.42) | FURINTPSAB1KRASMC4RMC5R | |
| SCHEMBL29568658 | 0.87 | GHSR (0.42) | FURINTPSAB1KRASMC4RMC5R | |
| SCHEMBL29568807 | 0.87 | GHSR (0.42) | FURINTPSAB1KRASMC4RMC5R | |
| SCHEMBL31328349 | 0.86 | CXCR4 (0.46) | TPSAB1KRASCXCR4 | |
| SCHEMBL14906469 | 0.82 | TPSAB1 (0.50) | TPSAB1SIRT2SIRT1SIRT3 | |
| Novexatin SCHEMBL29715903 | 0.82 | TPSAB1 (0.50) | TPSAB1SIRT2SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | AJK BIOPHARMACEUTICAL LLC (US) | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | VIP, HM13, NGLY1 | FURIN 526/4885TPSAB1 4483/4885KRAS 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.